Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease

Apr 13, 2001·JAMA : the Journal of the American Medical Association·S J RobinsUNKNOWN VA-HIT Study Group. Veterans Affairs High-Density Lipoprotein Intervention Trial

Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised study

Apr 6, 2001·Lancet

A selective peroxisome proliferator-activated receptor delta agonist promotes reverse cholesterol transport

Apr 20, 2001·Proceedings of the National Academy of Sciences of the United States of America·W R OliverT M Willson

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

May 23, 2001·JAMA : the Journal of the American Medical Association·UNKNOWN Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults

❮ Previous

Next ❯

Citations

Effects of dietary fucoidan on the blood constituents, anti-oxidation and innate immunity of juvenile yellow catfish (Pelteobagrus fulvidraco)

Sep 23, 2014·Fish & Shellfish Immunology·Qing YangZacharia Cassian Elmada

Increased disease activity is associated with a deteriorated lipid profile in patients with ankylosing spondylitis.

Apr 29, 2006·Annals of the Rheumatic Diseases·V P van HalmM T Nurmohamed

Lipids and inflammation: serial measurements of the lipid profile of blood donors who later developed rheumatoid arthritis

Jun 9, 2006·Annals of the Rheumatic Diseases·V P van HalmB A C Dijkmans

Risk of cardiovascular events in patients at optimal values for combined lipid parameters

Mar 16, 2007·Current Medical Research and Opinion·Eric J StanekMark J Cziraky

Can foods with added soya-protein or fish-oil reduce risk factors for coronary disease? A factorial randomised controlled trial

Apr 28, 2005·Nutrition, Metabolism, and Cardiovascular Diseases : NMCD·R A HarrisonY Yamori

Rapid screening of phytosterols in orange juice by solid-phase microextraction on polyacrylate fibre derivatisation and gas chromatographic-mass spectrometric

May 1, 2012·Food Chemistry·Sébastien Balme, Fazil O Gülaçar

Dietary alpha-linolenic acid, EPA, and DHA have differential effects on LDL fatty acid composition but similar effects on serum lipid profiles in normolipidemic humans

Mar 6, 2009·The Journal of Nutrition·Sarah EgertUrsel Wahrburg

PIK3CG single nucleotide polymorphisms are associated with poor responsiveness to clopidogrel and increased risk of ischemia in patients with coronary heart disease

Sep 9, 2017·Medicine·Ke-Cheng LiBao-Zhong Zhuge

Individual serum triglyceride responses to high-fat and low-fat diets differ in men with modest and severe hypertriglyceridemia

Jun 3, 2004·The Journal of Nutrition·Birgitta JacobsMario Kratz

❮ Previous

Next ❯

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Importance of high-density lipoprotein cholesterol and triglyceride levels in coronary heart disease

Abstract

References

High density lipoprotein cholesterol and incidence of coronary heart disease--the Israeli Ischemic Heart Disease Study

Clofibrate and niacin in coronary heart disease

Role of triglycerides in coronary artery disease: lessons from the Prospective Cardiovascular Münster Study

Epidemiology of triglycerides: a view from Framingham

Mechanism of plasma cholesteryl ester transfer in hypertriglyceridemia.

Apolipoproteins C-II and C-III metabolism in hypertriglyceridemic patients. Effect of a drastic triglyceride reduction by combined diet restriction and fenofibrate administration

Effect of low-dose niacin on high-density lipoprotein cholesterol and total cholesterol/high-density lipoprotein cholesterol ratio

Reduction of mortality in the Stockholm Ischaemic Heart Disease Secondary Prevention Study by combined treatment with clofibrate and nicotinic acid

Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts

Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease

High-density lipoprotein cholesterol and coronary heart disease in hypercholesterolemic men: the Lipid Research Clinics Coronary Primary Prevention Trial

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

High-density lipoproteins: epidemiologic profile and risks of coronary artery disease

Effects of clofibrate, bezafibrate, fenofibrate and probucol on plasma lipolytic enzymes in normolipaemic subjects

Lowering of HDL2b by probucol partly explains the failure of the drug to affect femoral atherosclerosis in subjects with hypercholesterolemia. A Probucol Quantitative Regression Swedish Trial (PQRST) Report

Fibrates increase human apolipoprotein A-II expression through activation of the peroxisome proliferator-activated receptor

Combined effects of HDL cholesterol, triglyceride, and total cholesterol concentrations on 18-year risk of atherosclerotic disease

Optimal risk factor management in the patient after coronary revascularization. A statement for healthcare professionals from an American Heart Association Writing Group

Coronary angiographic changes with lovastatin therapy. The Monitored Atherosclerosis Regression Study (MARS)

The Helsinki Heart Study: coronary heart disease incidence during an extended follow-up

An enzymatic explanation of the differential effects of oleate and gemfibrozil on cultured hepatocyte triacylglycerol and phosphatidylcholine biosynthesis and secretion

Angiographic assessment of effects of bezafibrate on progression of coronary artery disease in young male postinfarction patients

Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies

Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels

Relation of high TG-low HDL cholesterol and LDL cholesterol to the incidence of ischemic heart disease. An 8-year follow-up in the Copenhagen Male Study

Prevention of the angiographic progression of coronary and vein-graft atherosclerosis by gemfibrozil after coronary bypass surgery in men with low levels of HDL cholesterol. Lopid Coronary Angiography Trial (LOCAT) Study Group

Alterations in lipoprotein metabolism in peroxisome proliferator-activated receptor alpha-deficient mice.

Niacin decreases removal of high-density lipoprotein apolipoprotein A-I but not cholesterol ester by Hep G2 cells. Implication for reverse cholesterol transport

Effects of recombinant apolipoprotein A-I(Milano) on aortic atherosclerosis in apolipoprotein E-deficient mice

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study

Relationship between plasma LDL concentrations during treatment with pravastatin and recurrent coronary events in the Cholesterol and Recurrent Events trial

Lipoprotein changes and reduction in the incidence of major coronary heart disease events in the Scandinavian Simvastatin Survival Study (4S)

Normal triglyceride levels and coronary artery disease events: the Baltimore Coronary Observational Long-Term Study

Associations between lipoproteins and the progression of coronary and vein-graft atherosclerosis in a controlled trial with gemfibrozil in men with low baseline levels of HDL cholesterol

Mechanism of action of fibrates on lipid and lipoprotein metabolism

Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention

Triglycerides as a risk factor for coronary artery disease

3-Hydroxy-3-methylglutaryl CoA reductase inhibitors reduce serum triglyceride levels through modulation of apolipoprotein C-III and lipoprotein lipase

Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group

Relation between baseline and on-treatment lipid parameters and first acute major coronary events in the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS)

Secondary prevention by raising HDL cholesterol and reducing triglycerides in patients with coronary artery disease

A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits

Vaccine-induced antibodies inhibit CETP activity in vivo and reduce aortic lesions in a rabbit model of atherosclerosis

HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic Foundation

Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor

Relation of gemfibrozil treatment and lipid levels with major coronary events: VA-HIT: a randomized controlled trial